Johnson & Johnson Innovative Medicine discovers and develops medical solutions to address important unmet needs in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. At J&J Innovative Medicine, what matters most is
After 10 years of continuous growth, Janssen Japan (JPKK) business is faced with two years of solid growth in 2024 and 2025. This is an important period to ensure successful delivery of our performance goals. As